Manuscripts
Showing 1519 manuscripts.
Using a composite maternal-infant outcome measure in tuberculosis prevention studies among pregnant women
Citation
Grace Montepiedra, Soyeon Kim, Adriana Weinberg, Gerhard Theron, Timothy R Sterling, Sylvia M LaCourse, Sarah Bradford, Nahida Chakhtoura, Patrick Jean-Philippe, Scott Evans, Amita Gupta. Using a composite maternal-infant outcome measure in tuberculosis prevention studies among pregnant women. Clinical Infectious Diseases. 2021. PMID: 33146706Year
2022
Journal
Clinical Infectious Diseases
Study
P1078
Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy
Citation
Gerhard Theron, Sean Brummel, Lee Fairlie, Mauricio Pinilla, Katie McCarthy, Maxensia Owor, Lameck Chinula, Bonus Makanani, Avy Violari, Dhayendre Moodley, Nahida Chakhtoura, Renee Browning, Risa Hoffman, MG Fowler. Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy. Clinical Infectious Diseases. 2021. 73: e312-e320. PMID: 32564058Journal
Clinical Infectious Diseases
Study
1077BF, 1077FF
Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age
Citation
Christine E MacBrayne, Richard M Rutstein, Andrew A Wiznia, Bobbie Graham, Carmelita G Alvero, Lee Fairlie, Kathryn Lypen, Kathleen H George, Ellen Townley, Jack Moye Jr., Diane G Costello, Christina A Reding, Cristina Barroso Hofer, Herta M Crauwels, Xavier Woot de Trixhe, Lotke Tambuyzer, Simon Vanveggel, Magda Opsomer, Jennifer J Kiser, IMPAACT P1090 Protocol Team. Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age. AIDS. 2021. 35: 1413-1421. PMID: 33831904Journal
AIDS
Study
P1090
Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV
Citation
Jeremiah D Momper, Jiajia Wang, Alice Stek, David E Shapiro, Gwendolyn B Scott, Mary E Paul, Irma L Febo, Sandra Burchett, Elizabeth Smith, Nahida Chakhtoura, Kayla Denson, Kittipong Rungruengthanakit, Kathleen George, Derek Z Yang, Edmund V Capparelli, Mark Mirochnick, Brookie M Best, IMPAACT P1026s Protocol Team. Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV. AIDS. 2021. 35: 1191-1199. PMID: 34076612Journal
AIDS
Study
P1026S
Comparison of dried blood spot and plasma sampling for untargeted metabolomics
Citation
Nicole H. Tobin, Aisling Murphy, Fan Li, Sean S Brummel, Taha E. Taha, Friday Saidi, Maxie Owor, Avy Violari, Dhayendre Moodley, Benjamin Chi, Kelli D. Goodman, Brian Koos, Grace M. Aldrovandi. Comparison of dried blood spot and plasma sampling for untargeted metabolomics. Metabolomics. 2021. 17: 62. PMID: 34164733Journal
Metabolomics
Study
1077BF, 1077FF
Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir
Citation
Xiaomei I Liu, Jeremiah D Momper, Natella Y Rakhmanin, Dionna J Green, Gilbert J Burckart, Tim R Cressey, Mark Mirochnick, Brookie M Best, John N van den Anker, André Dallmann. Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir. Clinical Pharmacokinetics. 2021. 60: 795-809. PMID: 33527213Journal
Clinical Pharmacokinetics
Study
P1026S
Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With HIV
Citation
Gerhard Theron, Grace Montepiedra, Lisa Aaron, Katie McCarthy, Chakhtoura Nahida, Patrick Jean-Philippe, Bonnie Zimmer, Amy James Loftis, Tsungai Chipato, Teacler Nematadzira, Mandisa Nyati, Carolyne Onyango-Makumbi, Gaerolwe Masheto, James Ngocho, Fuanglada Tongprasert, Sandesh Patil, Dominique Lespinasse, Adriana Weinberg, Amita Gupta, IMPAACT P1078 TB APPRISE Study Team. Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With HIV. Clinical Infectious Diseases. 2021. PMID: 32997744Year
2022
Journal
Clinical Infectious Diseases
Study
P1078
IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes of Implementation
Citation
Jennifer Libous, Nicole A. Montañez, Dorothy E. Dow, Suad Kapetanovic, Janice Buckley, Tebogo Jacqueline Kakhu, Portia Kamthunzi, Limbika A. Maliwichi, Tichaona Vhembo, Tariro Dianah Chawana, Teacler Nematadzira, Geri R Doneberg. IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes of Implementation. Frontiers in Reproductive Health. 2021. 3: 1-9. PMID: 36303985Year
2021
Journal
Frontiers in Reproductive Health
Study
IMPAACT 2016
Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092
Citation
Maxensia Owor, Camlin Tierney, Lauren Ziemba, Renee Browning, John Moye, Bobbie Graham, Christina Reding, Diane Costello, Jennifer Norman, Lubbe Wiesner, Emma Hughes, Meghan E. Whalen, Lynette Purdue, Blandina Theophil Mmbaga, Portia Kamthunzi, Rachel Kawalazira, Kusum Nathoo, Sarah Bradford, Anne Coletti, Francesca Aweeka, Philippa Musoke. Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092. Pediatric Infectious Disease Journal. 2021. PMID: 33464021Journal
Pediatric Infectious Disease Journal
Study
P1092
Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens
Citation
Debika Bhattacharya, Amita Gupta, Camlin Tierney, Sharon Huang, Marion Peters, Tsungai Chipato, Frances Martinson, Neaka Mohtashemi, Dingase Dula, Kathy George, Nahida Chaktoura, Karin L Klingman, Devasena Gnanashanmugam, Judith S Currier, Mary G Fowler. Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens. Clinical Infectious Diseases. 2021. 72: 1342-1349. PMID: 32161944Journal
Clinical Infectious Diseases
Study
1077BF, 1077FF